To investigate the role of BRISC in LPS-induced inflammatory liver diseases, we established a mouse model of D-GalN/LPS-induced fatal hepatitis in global ABRO1 and BRCC3 knockout mice. Here, ABRAXAS2 is linked to liver disorder.